Home Applications 204251 Application 204251
Type NDA
Sponsor NOVARTIS Application Products# Product, Drug, Ingredient table Product Drug Ingredient Form Strength Reference drug Reference standard 001 SIMBRINZA BRIMONIDINE TARTRATE; BRINZOLAMIDE SUSPENSION/DROPS;OPHTHALMIC 0.2%;1% Yes Yes
Source provenance: Browse the complete Orange Book source catalog · source snapshot 45 .
Orange Book products# Current product rows page 1 of 1 · 1 matching rows.
Application-product, Trade name, Ingredient table Application-product Trade name Ingredient Strength Dosage form / route TE codes RLD / RS Approval date N204251-001 SIMBRINZA BRIMONIDINE TARTRATE; BRINZOLAMIDE 0.2%;1% SUSPENSION/DROPS / OPHTHALMIC RLD, RS 2013-04-19
Orange Book patents# Current patent rows page 1 of 1 · 2 matching rows.
Application-product, Patent, Expiration table Application-product Patent Expiration Use code Coverage / status Submission date N204251-001 9421265 2030-06-17 Drug product 2016-10-24 N204251-001 9044484 2030-10-30 Drug product 2015-06-09
Observed Orange Book product history# Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
Product history page 1 of 2 · 45 observed states.
Captured, Edition, Application-product table Captured Edition Application-product Trade name Strength Dosage form / route Product TE source text RLD / RS Approval date Source SHA-256 2026-11-14 07:37:17 2026-10 N204251-001 SIMBRINZA 0.2%;1% SUSPENSION/DROPS / OPHTHALMIC RLD, RS 2013-04-19 d4dbc9d85df4…2026-10-15 13:18:30 2026-09 N204251-001 SIMBRINZA 0.2%;1% SUSPENSION/DROPS / OPHTHALMIC RLD, RS 2013-04-19 c2088c7a36db…2026-09-14 22:38:34 2026-08 N204251-001 SIMBRINZA 0.2%;1% SUSPENSION/DROPS / OPHTHALMIC RLD, RS 2013-04-19 84e616aacf4f…2026-08-18 06:07:40 2026-07 N204251-001 SIMBRINZA 0.2%;1% SUSPENSION/DROPS / OPHTHALMIC RLD, RS 2013-04-19 caaa826d4ba7…2026-02-19 14:30 UTC 2026-02 N204251-001 SIMBRINZA 0.2%;1% SUSPENSION/DROPS / OPHTHALMIC RLD, RS 2013-04-19 011fe1cb6892…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N204251-001 SIMBRINZA 0.2%;1% SUSPENSION/DROPS / OPHTHALMIC RLD, RS 2013-04-19 31067a03dcf5…2025-08-23 18:47 UTC 2025-08 N204251-001 SIMBRINZA 0.2%;1% SUSPENSION/DROPS / OPHTHALMIC RLD, RS 2013-04-19 6a471c1ec25d…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 N204251-001 SIMBRINZA 0.2%;1% SUSPENSION/DROPS / OPHTHALMIC RLD, RS 2013-04-19 fd3edfee7708…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 N204251-001 SIMBRINZA 0.2%;1% SUSPENSION/DROPS / OPHTHALMIC RLD, RS 2013-04-19 b8a1b40f171c…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 N204251-001 SIMBRINZA 0.2%;1% SUSPENSION/DROPS / OPHTHALMIC RLD, RS 2013-04-19 03ed91905a0d…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 N204251-001 SIMBRINZA 0.2%;1% SUSPENSION/DROPS / OPHTHALMIC RLD, RS 2013-04-19 2680178bc6a6…2024-09-14 05:58 UTC · 2 captures of this ZIP 2024-09 N204251-001 SIMBRINZA 0.2%;1% SUSPENSION/DROPS / OPHTHALMIC RLD, RS 2013-04-19 5bbf6a4d5a75…2024-11-08 22:44 UTC · 3 captures of this ZIP 2024-11 N204251-001 SIMBRINZA 0.2%;1% SUSPENSION/DROPS / OPHTHALMIC RLD, RS 2013-04-19 d8e5a09893c0…2024-10-29 15:01 UTC 2024-10 N204251-001 SIMBRINZA 0.2%;1% SUSPENSION/DROPS / OPHTHALMIC RLD, RS 2013-04-19 d06236e962d9…2024-08-13 05:28 UTC · 3 captures of this ZIP 2024-08 N204251-001 SIMBRINZA 0.2%;1% SUSPENSION/DROPS / OPHTHALMIC RLD, RS 2013-04-19 79d66fd596c7…2024-07-13 05:37 UTC · 2 captures of this ZIP 2024-07 N204251-001 SIMBRINZA 0.2%;1% SUSPENSION/DROPS / OPHTHALMIC RLD, RS 2013-04-19 301d65b070ca…2024-06-18 03:08 UTC · 5 captures of this ZIP 2024-06 N204251-001 SIMBRINZA 0.2%;1% SUSPENSION/DROPS / OPHTHALMIC RLD, RS 2013-04-19 1e350fbaab3a…2024-05-31 18:47 UTC 2024-05 N204251-001 SIMBRINZA 0.2%;1% SUSPENSION/DROPS / OPHTHALMIC RLD, RS 2013-04-19 8072bd15b7f6…2022-06-29 02:47 UTC · 2 captures of this ZIP 2022-06 N204251-001 SIMBRINZA 0.2%;1% SUSPENSION/DROPS / OPHTHALMIC RLD, RS 2013-04-19 5c6f7cd8ea54…2022-04-08 23:34 UTC 2022-04 N204251-001 SIMBRINZA 0.2%;1% SUSPENSION/DROPS / OPHTHALMIC RLD, RS 2013-04-19 5d02ea3f76ae…2022-04-04 05:41 UTC 2022-04 N204251-001 SIMBRINZA 0.2%;1% SUSPENSION/DROPS / OPHTHALMIC RLD, RS 2013-04-19 4b0b4de00fa7…2019-12-13 00:20 UTC 2019-12 N204251-001 SIMBRINZA 0.2%;1% SUSPENSION/DROPS / OPHTHALMIC RLD, RS 2013-04-19 74a2ff9319b5…2022-03-09 01:35 UTC 2022-03 N204251-001 SIMBRINZA 0.2%;1% SUSPENSION/DROPS / OPHTHALMIC RLD, RS 2013-04-19 bb7c543d1eb4…2021-12-28 21:50 UTC 2021-12 N204251-001 SIMBRINZA 0.2%;1% SUSPENSION/DROPS / OPHTHALMIC RLD, RS 2013-04-19 782e0a99824c…2021-05-05 16:15 UTC · 3 captures of this ZIP 2021-05 N204251-001 SIMBRINZA 0.2%;1% SUSPENSION/DROPS / OPHTHALMIC RLD, RS 2013-04-19 87673890dc5c…2021-03-12 10:30 UTC 2021-03 N204251-001 SIMBRINZA 0.2%;1% SUSPENSION/DROPS / OPHTHALMIC RLD, RS 2013-04-19 5aa47cf7b7d7…2020-12-22 03:56 UTC 2020-12 N204251-001 SIMBRINZA 0.2%;1% SUSPENSION/DROPS / OPHTHALMIC RLD, RS 2013-04-19 8869cabd3fbd…2020-11-12 02:37 UTC 2020-11 N204251-001 SIMBRINZA 0.2%;1% SUSPENSION/DROPS / OPHTHALMIC RLD, RS 2013-04-19 c0c555d07b60…2019-12-14 00:12 UTC 2019-12 N204251-001 SIMBRINZA 0.2%;1% SUSPENSION/DROPS / OPHTHALMIC RLD, RS 2013-04-19 3f01610625f2…2019-09-15 20:21 UTC 2019-09 N204251-001 SIMBRINZA 0.2%;1% SUSPENSION/DROPS / OPHTHALMIC RLD, RS 2013-04-19 b00525d2431f…2019-07-19 19:46 UTC 2019-07 N204251-001 SIMBRINZA 0.2%;1% SUSPENSION/DROPS / OPHTHALMIC RLD, RS 2013-04-19 ea99ee380514…2024-03-16 18:09 UTC · 4 captures of this ZIP 2024-03 N204251-001 SIMBRINZA 0.2%;1% SUSPENSION/DROPS / OPHTHALMIC RLD, RS 2013-04-19 6a51e52b5d6a…2024-02-18 07:12 UTC 2024-02 N204251-001 SIMBRINZA 0.2%;1% SUSPENSION/DROPS / OPHTHALMIC RLD, RS 2013-04-19 1c564ffb4f44…2023-12-20 04:57 UTC 2023-12 N204251-001 SIMBRINZA 0.2%;1% SUSPENSION/DROPS / OPHTHALMIC RLD, RS 2013-04-19 ea1830bbd6c7…2023-11-28 05:40 UTC · 2 captures of this ZIP 2023-11 N204251-001 SIMBRINZA 0.2%;1% SUSPENSION/DROPS / OPHTHALMIC RLD, RS 2013-04-19 a72a2bbeb626…2023-10-25 00:34 UTC · 2 captures of this ZIP 2023-10 N204251-001 SIMBRINZA 0.2%;1% SUSPENSION/DROPS / OPHTHALMIC RLD, RS 2013-04-19 9b2671bbb829…2023-07-15 15:27 UTC · 2 captures of this ZIP 2023-07 N204251-001 SIMBRINZA 0.2%;1% SUSPENSION/DROPS / OPHTHALMIC RLD, RS 2013-04-19 a67488948f0b…2023-06-13 01:57 UTC · 3 captures of this ZIP 2023-06 N204251-001 SIMBRINZA 0.2%;1% SUSPENSION/DROPS / OPHTHALMIC RLD, RS 2013-04-19 3f0d92c62455…2023-05-13 08:27 UTC 2023-05 N204251-001 SIMBRINZA 0.2%;1% SUSPENSION/DROPS / OPHTHALMIC RLD, RS 2013-04-19 053a50430f4f…2023-01-26 05:58 UTC 2023-01 N204251-001 SIMBRINZA 0.2%;1% SUSPENSION/DROPS / OPHTHALMIC RLD, RS 2013-04-19 3bdfa0b2c4d7…
Observed Orange Book patent history# Patent history page 1 of 3 · 94 observed states.
Captured, Edition, Application-product table Captured Edition Application-product Patent Expiration Use code Coverage / status Submission date Source SHA-256 2026-11-14 07:37:17 2026-10 N204251-001 9421265 2030-06-17 Drug product 2016-10-24 d4dbc9d85df4…2026-11-14 07:37:17 2026-10 N204251-001 9044484 2030-10-30 Drug product 2015-06-09 d4dbc9d85df4…2026-10-15 13:18:30 2026-09 N204251-001 9421265 2030-06-17 Drug product 2016-10-24 c2088c7a36db…2026-10-15 13:18:30 2026-09 N204251-001 9044484 2030-10-30 Drug product 2015-06-09 c2088c7a36db…2026-09-14 22:38:34 2026-08 N204251-001 9421265 2030-06-17 Drug product 2016-10-24 84e616aacf4f…2026-09-14 22:38:34 2026-08 N204251-001 9044484 2030-10-30 Drug product 2015-06-09 84e616aacf4f…2026-08-18 06:07:40 2026-07 N204251-001 9421265 2030-06-17 Drug product 2016-10-24 caaa826d4ba7…2026-08-18 06:07:40 2026-07 N204251-001 9044484 2030-10-30 Drug product 2015-06-09 caaa826d4ba7…2026-02-19 14:30 UTC 2026-02 N204251-001 9421265 2030-06-17 Drug product 2016-10-24 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N204251-001 9044484 2030-10-30 Drug product 2015-06-09 011fe1cb6892…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N204251-001 9421265 2030-06-17 Drug product 2016-10-24 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N204251-001 9044484 2030-10-30 Drug product 2015-06-09 31067a03dcf5…2025-08-23 18:47 UTC 2025-08 N204251-001 9421265 2030-06-17 Drug product 2016-10-24 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 N204251-001 9044484 2030-10-30 Drug product 2015-06-09 6a471c1ec25d…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 N204251-001 9421265 2030-06-17 Drug product 2016-10-24 fd3edfee7708…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 N204251-001 9044484 2030-10-30 Drug product 2015-06-09 fd3edfee7708…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 N204251-001 9421265 2030-06-17 Drug product 2016-10-24 b8a1b40f171c…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 N204251-001 9044484 2030-10-30 Drug product 2015-06-09 b8a1b40f171c…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 N204251-001 9421265 2030-06-17 Drug product 2016-10-24 03ed91905a0d…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 N204251-001 9044484 2030-10-30 Drug product 2015-06-09 03ed91905a0d…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 N204251-001 9421265 2030-06-17 Drug product 2016-10-24 2680178bc6a6…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 N204251-001 9044484 2030-10-30 Drug product 2015-06-09 2680178bc6a6…2024-09-14 05:58 UTC · 2 captures of this ZIP 2024-09 N204251-001 9421265 2030-06-17 Drug product 2016-10-24 5bbf6a4d5a75…2024-09-14 05:58 UTC · 2 captures of this ZIP 2024-09 N204251-001 9044484 2030-10-30 Drug product 2015-06-09 5bbf6a4d5a75…2024-11-08 22:44 UTC · 3 captures of this ZIP 2024-11 N204251-001 9421265 2030-06-17 Drug product 2016-10-24 d8e5a09893c0…2024-11-08 22:44 UTC · 3 captures of this ZIP 2024-11 N204251-001 9044484 2030-10-30 Drug product 2015-06-09 d8e5a09893c0…2024-10-29 15:01 UTC 2024-10 N204251-001 9421265 2030-06-17 Drug product 2016-10-24 d06236e962d9…2024-10-29 15:01 UTC 2024-10 N204251-001 9044484 2030-10-30 Drug product 2015-06-09 d06236e962d9…2024-08-13 05:28 UTC · 3 captures of this ZIP 2024-08 N204251-001 9421265 2030-06-17 Drug product 2016-10-24 79d66fd596c7…2024-08-13 05:28 UTC · 3 captures of this ZIP 2024-08 N204251-001 9044484 2030-10-30 Drug product 2015-06-09 79d66fd596c7…2024-07-13 05:37 UTC · 2 captures of this ZIP 2024-07 N204251-001 9421265 2030-06-17 Drug product 2016-10-24 301d65b070ca…2024-07-13 05:37 UTC · 2 captures of this ZIP 2024-07 N204251-001 9044484 2030-10-30 Drug product 2015-06-09 301d65b070ca…2024-06-18 03:08 UTC · 5 captures of this ZIP 2024-06 N204251-001 9421265 2030-06-17 Drug product 2016-10-24 1e350fbaab3a…2024-06-18 03:08 UTC · 5 captures of this ZIP 2024-06 N204251-001 9044484 2030-10-30 Drug product 2015-06-09 1e350fbaab3a…2024-05-31 18:47 UTC 2024-05 N204251-001 9421265 2030-06-17 Drug product 2016-10-24 8072bd15b7f6…2024-05-31 18:47 UTC 2024-05 N204251-001 9044484 2030-10-30 Drug product 2015-06-09 8072bd15b7f6…2022-06-29 02:47 UTC · 2 captures of this ZIP 2022-06 N204251-001 9421265 2030-06-17 Drug product 2016-10-24 5c6f7cd8ea54…2022-06-29 02:47 UTC · 2 captures of this ZIP 2022-06 N204251-001 9044484 2030-10-30 Drug product 2015-06-09 5c6f7cd8ea54…2022-04-08 23:34 UTC 2022-04 N204251-001 9421265 2030-06-17 Drug product 2016-10-24 5d02ea3f76ae…2022-04-08 23:34 UTC 2022-04 N204251-001 9044484 2030-10-30 Drug product 2015-06-09 5d02ea3f76ae…
openFDA label cross-check# OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
Matched openFDA labels page 1 of 1 · 1 matching rows.
Brand, Generic, Manufacturer table Brand Generic Manufacturer SPL set ID Effective date Available safety fields Join SIMBRINZA BRINZOLAMIDE/BRIMONIDINE TARTRATE Alcon Laboratories, Inc. a49c157e-6310-0011-7b7f-e26fc1820d59 2025-03-11 Warnings, Adverse reactions Exact identifier application applno (NDA): 204251 application number: NDA204251 ndc (product): 0065-4147
Reported adverse events (FAERS/openFDA)# Adverse event summaries are temporarily unavailable. Other product information remains available.
NDC Listings For This Application# NDC listings for this application page 1 of 1 · 9 matching rows.
NDC, Name, Nonproprietary name table NDC Name Nonproprietary name Labeler Marketing category Status 0065-4147 SIMBRINZA brinzolamide/brimonidine tartrate Alcon Laboratories, Inc. NDA Current 0065-4147 SIMBRINZA brinzolamide/brimonidine tartrate Alcon Laboratories, Inc. NDA Current 0065-4147 SIMBRINZA brinzolamide/brimonidine tartrate Alcon Laboratories, Inc. NDA Current 0065-4147 SIMBRINZA brinzolamide/brimonidine tartrate Alcon Laboratories, Inc. NDA Current 0065-4147 SIMBRINZA brinzolamide/brimonidine tartrate Alcon Laboratories, Inc. NDA Current 0065-4147 SIMBRINZA brinzolamide/brimonidine tartrate Alcon Laboratories, Inc. NDA Current 0078-0904 SIMBRINZA brinzolamide/brimonidine tartrate Novartis Pharmaceuticals Corporation NDA Current 0078-0904 SIMBRINZA brinzolamide/brimonidine tartrate Novartis Pharmaceuticals Corporation NDA Current 0078-0904 SIMBRINZA brinzolamide/brimonidine tartrate Novartis Pharmaceuticals Corporation NDA Current
Documents# Document, Submission type, Date table Document Submission type Date 74186 SUPPL 2023-05-08 74185 SUPPL 2023-05-08 19538 SUPPL 2015-11-12 32532 SUPPL 2015-11-09 24463 ORIG 2013-09-26 22948 ORIG 2013-09-26 32531 ORIG 2013-04-24 19537 ORIG 2013-04-23